Management of high-risk (B3) breast lesions in symptomatic practice evidence review and practical recommendations for multidisciplinary care

This new guidance on the management of high risk (B3) breast lesions in symptomatic practice has been produced by the UK National Coordinating Committee for Breast Pathology and the European Working Group for Breast Screening Pathology